Search Results - "Kamuhabwa, Appolinary A"

Refine Results
  1. 1

    Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania by Bwire, George M., Ngasala, Billy, Mikomangwa, Wigilya P., Kilonzi, Manase, Kamuhabwa, Appolinary A. R.

    Published in Scientific reports (26-02-2020)
    “…In Tanzania, chloroquine was replaced by sulphadoxine- pyrimethamine (SP) as a first-line for treatment of uncomplicated malaria. Due to high resistance in…”
    Get full text
    Journal Article
  2. 2

    Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania by Mnkugwe, Rajabu Hussein, Minzi, Omary S, Kinung'hi, Safari M, Kamuhabwa, Appolinary A, Aklillu, Eleni

    Published in PloS one (05-02-2020)
    “…Schistosomiasis is a neglected tropical disease that continues to cause morbidity and mortality in Sub Saharan Africa. Due to its endemicity, co-infection with…”
    Get full text
    Journal Article
  3. 3

    Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio by Mlugu, Eulambius M, Minzi, Omary M, Kamuhabwa, Appolinary A R, Diczfalusy, Ulf, Aklillu, Eleni

    “…Changes in cortisol and other hormones during pregnancy may alter CYP3A enzymes activity, but data from sub-Saharan Africa are sparse. We investigated the…”
    Get full text
    Journal Article
  4. 4

    Optimal single sampling time-point for monitoring of praziquantel exposure in children by Mnkugwe, Rajabu Hussein, Ngaimisi Kitabi, Eliford, Kinung’hi, Safari, Kamuhabwa, Appolinary A. R., Minzi, Omary Mashiku, Aklillu, Eleni

    Published in Scientific reports (09-09-2021)
    “…Praziquantel pharmacokinetics studies in schistosomiasis infected children are scarce partly due to the challenges/complexity of intensive blood sampling in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania by Mikomangwa, Wigilya P, Minzi, Omary, Mutagonda, Ritah, Baraka, Vito, Mlugu, Eulambius M, Aklillu, Eleni, Kamuhabwa, Appolinary A R

    Published in Malaria journal (19-04-2020)
    “…Malaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥ 3 doses of sulfadoxine-pyrimethamine (SP) for intermittent…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy by Mlugu, Eulambius M, Minzi, Omary M S, Johansson, Mats, Kamuhabwa, Appolinary A R, Aklillu, Eleni

    Published in BMC pharmacology & toxicology (08-07-2024)
    “…Dihydroartemisinin-piperaquine (DHP) recently showed superior effectiveness over sulfadoxine-pyrimethamine for malaria intermittent preventive treatment in…”
    Get full text
    Journal Article
  8. 8

    Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region by Mikomangwa, Wigilya P, Oms, Minzi, Aklillu, Eleni, Kamuhabwa, Appolinary A R

    Published in BMC pregnancy and childbirth (08-07-2019)
    “…Malaria in pregnancy increases the risk of adverse birth outcomes such as low birth weight (LBW), maternal and foetal anemia. In Tanzania, some areas have…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women by Mutagonda, Ritah F, Kamuhabwa, Appolinary A R, Minzi, Omary M S, Massawe, Siriel N, Asghar, Muhammad, Homann, Manijeh V, Färnert, Anna, Aklillu, Eleni

    Published in Malaria journal (03-07-2017)
    “…Pregnancy has considerable effects on the pharmacokinetic properties of drugs used to treat uncomplicated Plasmodium falciparum malaria. The role of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Adherence, Effectiveness and Safety of Dolutegravir Based Antiretroviral Regimens among HIV Infected Children and Adolescents in Tanzania by Mutagonda, Ritah F., Mlyuka, Hamu J., Maganda, Betty A., Kamuhabwa, Appolinary A. R.

    “…Objectives:This study aimed at assessing adherence, effectiveness, and safety of DTG-based HAART regimens among HIV-infected children and adolescents in…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study by Fimbo, Adam M, Minzi, Omary Mashiku, Mmbando, Bruno P, Gurumurthy, Parthasarathi, Kamuhabwa, Appolinary A R, Aklillu, Eleni

    Published in Pharmaceuticals (Basel, Switzerland) (12-05-2022)
    “…Ivermectin and albendazole (IA) combination preventive chemotherapy to all at-risk populations is deployed to eliminate lymphatic filariasis. Although safety…”
    Get full text
    Journal Article
  15. 15

    Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women by Mutagonda, Ritah F, Kamuhabwa, Appolinary A R, Minzi, Omary M S, Massawe, Siriel N, Maganda, Betty A, Aklillu, Eleni

    Published in Malaria journal (13-05-2016)
    “…Day 7 plasma concentrations of lumefantrine (LF) can serve as a marker to predict malaria treatment outcome in different study populations. Two main cut-off…”
    Get full text
    Journal Article
  16. 16

    Prevalence and Correlates of Asymptomatic Malaria and Anemia on First Antenatal Care Visit among Pregnant Women in Southeast, Tanzania by Mlugu, Eulambius M, Minzi, Omary, Kamuhabwa, Appolinary A R, Aklillu, Eleni

    “…Asymptomatic malaria and anemia during pregnancy increase the risk of negative birth outcomes. This cross-sectional study investigated the prevalence and…”
    Get full text
    Journal Article
  17. 17

    Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations by Mutagonda, Ritah F, Minzi, Omary M S, Massawe, Siriel N, Asghar, Muhammad, Färnert, Anna, Kamuhabwa, Appolinary A R, Aklillu, Eleni

    Published in Drug metabolism and disposition (01-12-2019)
    “…Pregnancy and pharmacogenetics variation alter drug disposition and treatment outcome. The objective of this study was to investigate the effect of pregnancy…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania by Mnkugwe, Rajabu Hussein, Minzi, Omary S, Kinung'hi, Safari M, Kamuhabwa, Appolinary A, Aklillu, Eleni

    Published in Pathogens (Basel) (01-01-2020)
    “…Single-dose targeted praziquantel preventive chemotherapy is the WHO-recommended intervention for schistosomiasis control in endemic countries. The objective…”
    Get full text
    Journal Article
  20. 20